Papers

50 results
Network meta-analysis comparing blood cardioplegia, Del Nido cardioplegia and custodiol cardioplegia in minimally invasive cardiac surgery.
Chan J, Oo S, Butt S, Benedetto U, Caputo M, Angelini GD, Vohra HA - Perfusion, March 01, 2022 5 citations
P
adult patients undergoing minimally invasive cardiac surgery
I/C
Del Nido cardioplegia, Custoidol solution, blood cardioplegia, crystalloid cardioplegia, Del Nido cardioplegia vs Blood, Custoidol solution vs Blood
O
in-hospital or 30-day mortality
Del Nido Cardioplegia in Adult Cardiac Surgery: Meta-Analysis of Randomized Clinical Trials.
Fresilli S, Labanca R, Monaco F, Belletti A, D'Amico F, Blasio A, Kotani Y, Landoni G, null null - Journal of cardiothoracic and vascular anesthesia, April 21, 2023 5 citations
P
adult patients (≥18 years old)
I/C
del Nido cardioplegia, other cardioplegias
O
postoperative stroke and/or transient ischemic attack rate, aortic cross-clamp time, need for defibrillation, postoperative acute kidney injury, mortality
P
Dr. Somovilla del Saz
I/C
vaccination against COVID-19, self-controlled case series studies
O
all-cause and cardiac-related mortality
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.
Meza N, Pérez-Bracchiglione J, Pérez I, Carvajal C, Ortiz-Muñoz L, Olguín P, Rada G, Madrid E, null null - Medwave, April 09, 2021 3 citations
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
Are oral oestrogens effective in preventing urinary tract infection in postmenopausal woman.
Castro V, Canales JP, Rada G - Medwave, July 01, 2020 0 citations
P
mujeres postmenopáusicas
I/C
uso de estrógenos
O
infección del tracto urinario sintomática
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.
Aparisi Á, Catalá P, Amat-Santos IJ, Marcos-Mangas M, López-Otero D, Veras C, López-Pais J, Cabezón-Villalba G, Cacho Antonio CE, Candela J, Antúnez-Muiños P, Gil JF, González Ferrero T, Rojas G, Pérez-Poza M, Uribarri A, Otero-García O, García-Granja PE, Jiménez Ramos V, Revilla A, Dueñas C, Gómez I, González-Juanatey JR, San Román JA - Medicina clinica, June 06, 2021 11 citations
P
hypertensive COVID-19 patients
I/C
chronic use of RAAS inhibitors, ACEIs and ARBs among hypertensive patients
O
all-cause mortality
Hand-washing promotion for preventing diarrhoea.
Ejemot-Nwadiaro RI, Ehiri JE, Arikpo D, Meremikwu MM, Critchley JA - The Cochrane database of systematic reviews, February 05, 2021 24 citations
P
54,471 participants
I/C
hand-washing promotion, no intervention
O
diarrhea episodes
P
patients with risk factors for surgical-site complications
I/C
prophylactic use of a specific single-use negative-pressure wound therapy (sNPWT) device, conventional dressings
O
surgical-site infection (SSI), wound dehiscence, seroma, necrosis, mean length of hospital stay
Prevalence of chronic obstructive pulmonary disease and chronic bronchitis in eight countries: a systematic review and meta-analysis.
Jarhyan P, Hutchinson A, Khaw D, Prabhakaran D, Mohan S - Bulletin of the World Health Organization, March 10, 2022 36 citations
P
I/C
O
Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.
Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A - The Cochrane database of systematic reviews, June 08, 2021 6 citations
P
people being investigated for tuberculosis
I/C
Xpert MTB/RIF, smear microscopy
O
mortality, proportion of participants starting tuberculosis treatment who had a successful treatment outcome, proportion of participants who were treated for tuberculosis, proportion of participants with bacteriological confirmation who were lost to follow-up pre-treatment, proportion of treated participants who had bacteriological confirmation
CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.